Implantica Announces Another Major European Center of Excellence in Italy starting with the RefluxStop™ procedure
Implantica AG (publ), a medtech company at the forefront of bringing advanced technology into the body, today announces that the first RefluxStop™ procedures to treat gastroesophageal reflux disease (GERD) have been performed in one of the top anti-reflux centers in Europe – IRCCS Ospedale Galeazzi - Sant'Ambrogio in Milan, Italy.The two RefluxStop™ procedures were successfully performed by Professor Davide Bona, Director of the General Surgery Operative Unit at I.R.C.C.S. Ospedale Galeazzi-Sant'Ambrogio in Milan, Italy and Associate Professor of General Surgery, University of Milan, joined